MAGELLAN LONGEVITY
Home › Open evidence dataset

The Magellan Longevity Open Evidence Dataset

Version 1.0.0Released 2026-08-11CC BY 4.0 — attribution required130 products · 2692 study records
130graded products
2692study-level rows
2646distinct PubMed IDs
2346rows with a DOI
3421product↔study citation links

What this is

Magellan Longevity grades every product it lists on the strength of the human evidence behind it, and links each grade to the primary literature it rests on. This dataset is that entire judgement, exported in full and given away: 130 products with their grade, the reason for the grade, the caveat that qualifies it, the dose actually used in human trials, the mechanistic pathway, and every PubMed identifier behind it — plus a second table of 2692 study-level records covering 2646 distinct PubMed identifiers and 2346 DOIs.

It exists because evidence grading in consumer health is almost always a black box. Sites publish a badge and never publish the reasoning, the citation list, or the cases where the evidence went the other way. Everything here is machine-readable and auditable, including the 1 product graded “Tested — did not work” and the 144 study records whose own conclusion reports no difference. Null results are part of the dataset by design — a catalogue that only ever surfaces flattering studies is marketing in a lab coat.

The grades in this file are not a re-derivation for publication. They are produced by executing the exact grading code that renders the live product pages, so the dataset cannot drift from what a reader sees on the site.

Download

Every file is UTF-8, licensed CC BY 4.0, and free. CSVs follow RFC 4180. The two tables share an identical schema across all three formats — the JSON and JSONL are not reduced versions of the CSV.

FileTableRowsFieldsSizeSHA-256 (first 16)
products.csvproducts13032230 KBa89ee19e4cba9e88
products.jsonproducts13032324 KB79311cf951f2936f
products.jsonlproducts13032307 KB435208675fa8185c
studies.csvstudies2692322.1 MB113ed23822b0aff1
studies.jsonstudies2692323.9 MB22cdcc06203226e8
studies.jsonlstudies2692323.6 MBe22d1b73d4274a28

Supporting files: data-dictionary.json · data-dictionary.md · dictionary as a web page · datapackage.json (Frictionless) · dataset-metadata.json (schema.org) · CITATION.cff · citation.bib · citation.ris · LICENSE.txt · checksums.txt · README.md

# verify what you downloaded
sha256sum -c checksums.txt

# 10 strongest-evidence products, straight from the CSV
python3 -c "import csv;[print(r['evidence_grade'],r['product_name'])\
 for r in csv.DictReader(open('products.csv')) if r['evidence_tier_key']=='strong']"

What is in each table

Table 1 — products (130 rows × 32 fields)

One row per catalogue product. Beyond identity and category it carries evidence_grade, grade_rationale, grade_caveat, studied_dose and dietary_dose, pathway_name, citation_count, the semicolon-separated pmids, and study_keys to join into table 2. A verbatim key_finding_quote records the single sentence used to justify the pathway assignment — quoted, never paraphrased into a stronger claim.

Table 2 — studies (2692 rows × 32 fields)

One row per study record: pmid, doi, journal, year, title, the compound it supports, the outcome in the source's own words, and reported_direction — a coarse rule-based reading of which way the source itself says the result went. 314 rows also carry a full structured write-up: research question, hypothesis, methods, results, conclusion and stated limitations. Filter is_primary_record_for_pmid to reduce the table to 2646 unique papers.

Join: products.study_keys → split on ;studies.study_key. The full field-by-field dictionary is at /data/data-dictionary.html.

How it was built

A single dependency-free Node script (tools/build_dataset.js) reads five files from the live site and writes every artefact on this page. Nothing is hand-edited between generation and publication, and no number on this page is typed by hand — each one is computed at build time.

SourceWhat is taken from it
data.jsThe catalogue: products, categories, compound monographs and the full study index.
study-writeups.js314 structured study write-ups (question, hypothesis, methods, results, conclusion, limitations, takeaway).
dosedata.jsPer-compound dose actually used in human trials, and the dose obtainable from food.
index.htmlThe grading rubric and the grading function itself — extracted and executed, so the exported grade is byte-for-byte the grade the site renders.
sitemap.xmlThe authoritative list of live monograph URLs, so no row links anywhere that does not exist.

Empty means not recorded in the source. No value is imputed, rounded up, or filled in from memory: where the catalogue has no DOI, the DOI cell is blank; where no human dose range has been established, studied_dose is blank rather than guessed.

The grading rubric, in full

Ingestibles and interventions are graded on the strength of human evidence for the active compound. Diagnostics and wearables are graded on how well the thing they measure predicts health — not on a treatment effect. These are the tier definitions exactly as published on the site, with the number of products that currently sit in each.

TierLetterDefinitionProducts
Strong evidenceAConsistent randomized human trials — or large, convergent human cohort data, sometimes backed by genetic (Mendelian) evidence — show a real benefit. That benefit is often a specific, measurable outcome (blood pressure, blood glucose, joint pain, muscle strength) rather than proof of a longer lifespan; each product’s page and caveat say exactly what the strong evidence is <i>for</i>.11
Moderate evidenceBSeveral human studies point the same way, but with limits — size, duration, funding, or mixed results.74
Emerging evidenceCMechanism is plausible and early human data exists, but it is small, short, or not yet replicated.20
PreliminaryC-Mostly mechanistic or animal data, or very few human studies. Interesting, not proven.4
Measurement toolBA test or sensor. Graded on what the marker predicts and how reliably it measures it.20
Tested — did not workDAdequately tested in humans and the result was negative. This is not thin evidence — it is sufficient evidence pointing at no benefit, which is why it is graded below Preliminary rather than above it.1

For well-characterized compounds, a board-certified physician assigns the grade from the human and mechanistic literature, and we publish a typical dose only where a verified standard range exists. For the long tail of ingredients, the grade is derived conservatively from the peer-reviewed studies we link on the page, and is capped below “Strong” until it has been individually reviewed. Effect statements shown on product pages are quoted verbatim from a cited study — we never paraphrase findings into stronger claims than the authors made.

We show null and negative evidence too. Where human trials are inconsistent or have failed to show benefit, we say so on the product page. A marketplace that only ever surfaces flattering studies is marketing in a lab coat.

Editorial firewall. Inclusion is never paid. No brand can buy a listing, a grade, or placement. We are not sponsored by and do not sell our own supplement line — so we are never stuck defending a bottle we make.

Each grade also carries how it was reached: curated_compound (104), curated_product (26). Open the full methodology in the Magellan store →

What the dataset says about itself

These are the aggregate numbers a reader or a journalist would want before citing anything. All are computed from the released files.

Distribution of evidence grades

GradeProductsShareMedian citations per product
Strong evidence118.5%20
Moderate evidence7456.9%21
Emerging evidence2015.4%21
Preliminary43.1%21
Measurement tool2015.4%22
Tested — did not work10.8%22

Across the catalogue the median product carries 21 peer-reviewed citations; the total number of product-to-study links is 3421.

Direction of effect reported by the sources

Reported directionStudy rowsShare
favorable97136.1%
mixed973.6%
no_difference1445.3%
unfavorable1154.3%
unclear136550.7%

Read this honestly. reported_direction is a deterministic keyword cascade over the source's own summary sentence, not an appraisal and not a language model. unclear (50.7% of rows) means no cue matched — usually a descriptive or mechanistic conclusion — and must not be read as a null result. Every classified row carries direction_evidence, the exact phrase that triggered it, so you can audit or discard any row. The rule set is documented in full in the data dictionary.

Publication years of the evidence base

PeriodStudy rowsShare
before 2000511.9%
2000–200927010.0%
2010–201432612.1%
2015–201970626.2%
2020–202266024.5%
2023–202444916.7%
2025 and later2308.5%

Range 1971–2026, median 2019, across 2692 rows carrying a year.

Most-cited journals

JournalStudy rows
Nutrients112
Am J Clin Nutr41
Cochrane Database Syst Rev38
J Cosmet Dermatol33
Phytother Res25
PLoS One25
Sci Rep21
Int J Environ Res Public Health19
BMJ18
Br J Nutr17
JAMA17
N Engl J Med16

1153 distinct journals appear in the dataset.

Mechanistic pathways covered

PathwayProducts
Cardiovascular & Vascular20
Muscle & Bone15
Circadian & Stress14
Biomarkers & Biological Age11
Connective Tissue11
Redox / Antioxidant10
NAD⁺ / Sirtuin Axis9
Environmental Exposure7
Gut–Immune Axis7
AMPK / Metabolic5
Brain & Cognition3
Mitochondrial Energy3

24 distinct pathways in total — the pathway taxonomy is rendered visually at /pathway-universe.html.

Preview

Fifteen rows from products.csv, strongest evidence first. The full table of all 130 rows is browsable at /data/evidence-grades.html.

ProductGradePathwayCitationsStudied dose
Creatine MonohydrateStrong evidenceMuscle & Bone233–5 g/day (creatine monohydrate); an optional ~20 g/day loading week works faster but…
Betaine (TMG)Strong evidenceEpigenetic / TCA231.5–6 g/day in trials
Bright Light Therapy LampStrong evidenceCircadian & Stress21~10,000 lux white light for ~30 min each morning
Hand Grip Dynamometer ProStrong evidenceMuscle & Bone21
Lutein and ZeaxanthinStrong evidenceBrain & Cognition2110 mg lutein + 2 mg zeaxanthin daily (the AREDS2 formulation)
Validated Home BP MonitorStrong evidenceCardiovascular & Vascular20
Azelaic Acid GelStrong evidenceGut–Immune Axis2015-20% topical gel/cream (prescription strengths used in most trials)
Daily Mineral SPF SunscreenStrong evidenceConnective Tissue19Daily broad-spectrum SPF 15 or higher, applied in adequate amounts
Balance and Strength TrainerStrong evidenceMuscle & Bone19Balance-challenging exercise ~3+ hours/week; strength training ~30–60 min/week
24h Ambulatory BP MonitorStrong evidenceCardiovascular & Vascular19
Voltaren Arthritis Pain Gel (Diclofenac 1%)Strong evidenceNSAID / Prostaglandin171% gel (~2–4 g) over the joint up to 4×/day; relief builds over ~7 days
Double Wood NMN CapsulesModerate evidenceNAD⁺ / Sirtuin Axis34Human RCTs used 250–1,200 mg/day orally; well-tolerated up to ~900 mg/day, with one…
Nutricost NMN Capsules 500mgModerate evidenceNAD⁺ / Sirtuin Axis34Human RCTs used 250–1,200 mg/day orally; well-tolerated up to ~900 mg/day, with one…
NOVOS Boost NMNModerate evidenceNAD⁺ / Sirtuin Axis34Human RCTs used 250–1,200 mg/day orally; well-tolerated up to ~900 mg/day, with one…
NMN Complex 1000 mg (Micro Ingredients)Moderate evidenceNAD⁺ / Sirtuin Axis34Human RCTs used 250–1,200 mg/day orally; well-tolerated up to ~900 mg/day, with one…

Limitations you should know before citing this

Licence and how to cite

Released under the Creative Commons Attribution 4.0 International (CC BY 4.0). You may share and adapt it for any purpose, including commercially. You must give credit, link to the licence, and indicate whether you made changes. In practice that means: if you use these grades or this citation graph, name the source and link back.

APA

Radu, G. (2026). Magellan Longevity Open Evidence Dataset (Version 1.0.0) [Data set]. Magellan Longevity. https://magellanlongevity.com/data/

BibTeX

@dataset{magellan_longevity_evidence_2026, author = {Radu, Gabriel}, title = {Magellan Longevity Open Evidence Dataset}, year = {2026}, version = {1.0.0}, publisher = {Magellan Longevity}, url = {https://magellanlongevity.com/data/}, license = {CC-BY-4.0}, note = {130 graded longevity products and 2692 linked study records} }

Plain attribution line

Magellan Longevity Open Evidence Dataset v1.0.0 (Gabriel Radu, DO, 2026), https://magellanlongevity.com/data/ — CC BY 4.0

Machine-readable citation metadata: CITATION.cff, BibTeX, RIS. Third-party article titles, journal names and short quoted findings remain subject to their publishers' terms; no full texts or complete abstracts are redistributed.

Versioning

v1.0.0 — 2026-08-11. First public release: 130 product rows, 2692 study rows, 2646 distinct PubMed identifiers. Schema frozen at 32 product fields and 32 study fields.

Releases are semantic: a patch changes values only, a minor release adds fields or rows, a major release changes or removes a field. Every release ships its own checksums.txt so a downstream user can prove which cut they analysed.

Related on Magellan

The longevity research map

The same citation graph rendered as a browsable map instead of a CSV.

Pathway universe

The 24 mechanistic pathways in pathway_name, visualised.

Evidence-graded supplement guide

The narrative version of table 1, written for readers rather than machines.

NMN, graded

A worked example: how one compound's row is assembled from its trials.

Creatine, graded

One of the 11 entries carrying the Strong evidence tier.

Senolytics

Where the mechanistic case runs far ahead of the human data.

Spermidine

Strong cohort data, a null 12-month trial — both kept in the dataset.

Omega-3

A large, well-replicated literature and where its limits are.

Berberine

Metformin-like effect sizes, small and short trials.

Questions

Can I use this dataset commercially?

Yes. It is published under Creative Commons Attribution 4.0 International (CC BY 4.0), which permits sharing and adaptation for any purpose including commercial use, provided you credit Gabriel Radu, DO / Magellan Longevity, link to the licence, and state whether you changed anything.

How is an evidence grade assigned?

For well-characterized compounds, a board-certified physician assigns the grade from the human and mechanistic literature, and we publish a typical dose only where a verified standard range exists. For the long tail of ingredients, the grade is derived conservatively from the peer-reviewed studies we link on the page, and is capped below “Strong” until it has been individually reviewed. Effect statements shown on product pages are quoted verbatim from a cited study — we never paraphrase findings into stronger claims than the authors made.

Does the affiliate relationship influence the grades?

No. Inclusion is never paid. No brand can buy a listing, a grade, or placement. We are not sponsored by and do not sell our own supplement line — so we are never stuck defending a bottle we make. Every row carries a grade_caveat field that states the limits of the evidence, and null and negative results are kept in the dataset rather than filtered out.

How current is the dataset?

Version 1.0.0 was cut on 2026-08-11. The literature it draws on spans 1971 to 2026, with a median publication year of 2019. Prices are a snapshot from the release date and should not be treated as live.

Is this a systematic review?

No, and it should not be cited as one. It is a transparent catalogue-level evidence map: it records which papers the site relies on for each product, what those papers concluded in their own words, and how strong that body of evidence was judged to be. It does not apply GRADE, does not perform meta-analysis, and does not claim exhaustive literature capture.

Educational information, not medical advice. Evidence grades describe the strength of published human research — they are not clinical recommendations, and nothing in this dataset is intended to diagnose, treat, cure or prevent any disease. Talk to your own clinician before starting or stopping anything.

Scientific content is reviewed by Gabriel Radu, DO, a board-certified physiatrist (NY licence 275110, NPI 1376861765). See the methodology page in the store →